Benefit of Repetitive Intrathecal Triamcinolone Acetonide Therapy in Predominantly Spinal Multiple Sclerosis: Prediction By Upper Spinal Cord Atrophy

Intrathecal injection of triamcinolone acetonide (TCA) has been shown to provide substantial benefit in a subset of progressive multiple sclerosis (MS) patients with predominant spinal symptoms. We examined whether atrophy of the upper spinal cord (USC) as measured by MRI can serve as a predictive m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lukas, Carsten, Bellenberg, Barbara, Hahn, Horst K., Rexilius, Jan, Drescher, Robert, Hellwig, Kerstin, Köster, Odo, Schimrigk, Sebastian
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2009
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3002603/
https://ncbi.nlm.nih.gov/pubmed/21180629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285609343480
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados